A Resource for Healthcare and Social Services Professionals
January 29, 2018
8:00 am–4:00 pm ET
This FREE course educates physicians, nurse practitioners, and physician assistants on prescribing buprenorphine for the treatment of opioid use disorder. SNOW DATE: March 1.
Boston Medical Center
801 Massachusetts Avenue
2nd Floor, room 2128
Boston, MA
This eight-hour course prepares physicians, nurse practitioners, and physician assistants to prescribe buprenorphine to treat opioid use disorder in their office. The curriculum includes the science of addiction as a brain disorder, the pharmacology of buprenorphine, and the regulatory requirements around prescribing this medication. Attendees will learn to screen patients for treatment with buprenorphine and to manage the medication along with the patient's other medical needs in an office setting such as a primary care clinic. The course fulfills 8 hours of the training needed to obtain a waiver to prescribe buprenorphine. The Drug Addiction Treatment Act of 2000 (DATA 2000) requires physicians to complete 8 hours of approved training in order to be eligible for a waiver, and nurse practitioners and physician assistants to complete 24 hours. Check-in for the course will be from 7:30 to 8:00 am and the training will run from 8:00 am to 4:00 pm. Breakfast and lunch will be provided. Validated parking is available ONLY for the Crosstown Center Garage, located at 7 Melnea Cass Boulevard, Boston MA, 02119. The garage is directly behind the training venue. This is an in-person training. There will not be an option to attend via webinar.
Physicians (MD, DO), Nurse Practitioners, and Physician Assistants
Upon completion of this training, the participants will (be able to): Have the training required to apply for a waiver to prescribe buprenorphine to their patients with opioid dependence (addiction), Identify and assess patients who are appropriate for treatment with buprenorphine, Have the specific knowledge concerning the use of buprenorphine to manage opioid dependence in the outpatient setting, Discuss the psychiatric and medical co-morbidities associated with opioid addiction.
PCSS Physician Clinical Support System, Boston Medical Center (BMC), Massachusetts Department of Public Health (DPH), American Academy of Addiction Psychiatry (AAAP), and the Massachusetts Bureau of Substance Abuse Services (BSAS).
AMA Credit Designation Statement American Academy of Addiction Psychiatry (AAAP) designates this live educational activity for a maximum of 8 (eight) AMA PRA Category 1 Credits. Physicians should only claim credit commensurate with the extent of their participation in the activity. Funding for this initiative was made possible (in part) by Providers Clinical Support System for Medication Assisted Treatment (5U79TI024697) from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government. Eligible attendees will be able to obtain CMEs from AAAP after the event takes place.
Grayken Center for Addiction TTA is a program of Boston Medical Center (BMC), a 514-bed academic medical center located in Boston's historic South End and the largest safety-net hospital in New England.
The content on this site and the content presented by Grayken Center for Addiction TTA is intended solely to inform and educate healthcare and social service professionals, and shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional. The hospital, the program, and the contributors are not acting as health care providers or professional consultants on behalf of any specific patient and disclaim establishing a provider-patient relationship with any specific patient.